Aeglea BioTherapeutics
Why Robinhood?
You can watch AGLE and buy or sell other stocks, ETFs, and their options commission-free!About AGLE
Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency.
AGLE Key Statistics
Stock Snapshot
With a market cap of 714.81M, Aeglea BioTherapeutics(AGLE) trades at $11.75. The stock has a price-to-earnings ratio of -15.41.
On 2026-02-11, Aeglea BioTherapeutics(AGLE) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Aeglea BioTherapeutics(AGLE) stock has reached 0, versus its average volume of 582.24K.
The stock's 52-week range extends from a low of $10.91 to a high of $35.58.
The stock's 52-week range extends from a low of $10.91 to a high of $35.58.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.